as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
0.56%
Downside
0.04%
Upside
52 Week's Low
52 Week's High
10.59%
Downside
20.47%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$122.1B
EPS (TTM)
4.5007
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
0.02%
PE Ratio (TTM)
16.57
Industry PE ratio
19.200384615384614
PEG Ratio
0.7642
EBITDA
12.3B
Revenue (TTM)
45.9B
Profit Margin
19.84%
Return On Equity TTM
8.84%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Today (16.57x)
November 29, 2025
Industry (19.20x)
November 29, 2025
Highest (14.50x)
June 30, 2021
Today’s Price to Earnings Ratio: 16.57x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $122.1B | -2.44% | 16.57 | 19.84% | |
| BUY | $990.0B | 629.43% | 54.05 | 30.99% | |
| BUY | $402.4B | 117.08% | 172.47 | 4.00% | |
| BUY | $500.1B | 43.69% | 20.03 | 27.26% | |
| BUY | $261.3B | 31.27% | 13.84 | 29.63% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹1,08,784
Returns
₹8,784
(+8.78%)
Returns from Sanofi Stock
₹2,908 (+2.91%)
Dollar Returns*
₹5,876 (+5.88%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $60.13
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
17.01%UPSIDE
Target Price
$60.13
Current Price
$49.9
Analyzed by
31 Analysts
Target
$60.13
Sanofi target price $60.13, a slight upside of 17.01% compared to current price of $49.9. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has dropped by -13.69% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Sanofi Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:12% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 28 November
Fri, 12:49 PM
-Sanofi receives EU approval for Dupixent to treat chronic spontaneous urticaria in patients aged 12 and above.
Sat, 02:31 AM
-Sanofi invests 50 million euros in Le Trait site to boost Dupixent production amid rising demand.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Sanofi has shown strong revenue growth over the last four quarters, increasing from $7.63 billion to $13.17 billion. This represents an average quarterly increase of 15.9%.
Price Rise
![]()
In the last 7 days, SNY stock has moved up by 0.5%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 195.5% return, outperforming this stock by 186.8%
Against Peers
![]()
In the last 1 year, Eli Lilly And Company has given 35.2% return, outperforming this stock by 32.3%
Profit Down
![]()
Sanofi's net profit has decreased for the last two quarters, falling from $3.94 billion to $2.80 billion. This represents an average decline of 28.9% per quarter.
| Organisation | Sanofi |
| Headquarters | 46, avenue de la Grande Armée, Paris, France, 75017 |
| Industry | Health Technology |
| CEO | Mr. Paul Hudson |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Olivier Charmeil | Executive Vice President of General Medicines |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Mr. Felix Lauscher | Head of IR North America & Asia |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Mr. Thomas Kudsk Larsen | Head of Investor Relations |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Mr. Paul Hudson | CEO & Director |
Mr. François-Xavier Roger | Executive VP & CFO |
Sanofi share price today is $49.9 as on at the close of the market. Sanofi share today touched a day high of $49.92 and a low of $49.62.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.62 on . Sanofi stock price today i.e. is closed at $49.9,which is 16.99% down from its 52 week high and 11.84% up from its 52 week low.
Sanofi market capitalisation is $0.12T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $49.9 as on November 28, 2025 at 11:29 pm IST, you will get 0.2004 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given -2.44% share price returns and 20.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?